Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 346

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 346
---
 which furnished a copy of
TuHURA’s press release.

On November 25, 2024, the Kineta and TuHURA management teams discussed staffing, secondary products,
clinical study and public announcements, via videoconference.

On November 25 and November 29, 2024, Kineta and TuHURA
management teams discussed diligence and scientific review via videoconference.

On November 26, 2024 and December 4, 2024,
Mr. Philips and Dr. Bianco further discussed terms of the proposed transaction via telephone calls.

Also on November 26,
2024, Kineta management introduced Party P, via email, to Kineta’s Lassa Fever (LHF535) program, which would constitute a Permitted Asset Disposition related to the sale of non-Program Assets given TuHURA
and Kineta executed the non-binding letter of intent on November 13, 2024.

On
November 27, 2024, Orrick sent a revised draft of the Merger Agreement to Foley, which, among other things, (i) revised the Company Fully Diluted Stock definition to distinguish between treatment of in-the-money and out-of-the money options; (ii) revised timing of delivery of the closing schedule to within 90 days of
Closing and review of such schedule to 45 days; (iii) added carve outs to allow for the disposition of non-Program Assets (iv) added covenants regarding employee matters; (v) removed TuHURA
stockholder approval of an increase of authorized shares of TuHURA Common Stock as a closing condition; (vi) revised the outside date for the termination right to April 30, 2025 and extension period if the SEC had not yet declared the
registration statement effective to 30 days; and (vii) removed TuHURA’s right to terminate the Merger Agreement at any time prior to the Kineta Stockholder Approval being obtained if Kineta is in default of the CTF Agreement.

Also on November 27, 2024, Kineta management and GigaGen discussed, via email, diligence and timing of a Permitted Asset Disposition
related to the sale of non-Program Assets given TuHURA and Kineta executed the non-binding letter of intent on November 13, 2024.

On December 2, 2024, Kineta management extended the exclusivity period to HCRX via email.

218

On December 3, 2024, a tele